Drugs / SD-IIV3
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07485855 Comparator | Dec 2025 → Apr 2027 expected | hematopoietic and lymphoid cell neoplasm, influenza | Asan Medical Center | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SD-IIV3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07485855 ↗ |
| Known as | Standard-dose trivalent inactivated influenza vaccine | “Standard-dose trivalent inactivated influenza vaccine (SD-IIV3)” NCT07485855 ↗ |
| Route | Intramuscular | “Single intramuscular injection administered during the influenza season.” NCT07485855 ↗ |